Cargando…

Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses

BACKGROUND: Methylene diphenyl diisocyanate (MDI), a reactive chemical used for commercial polyurethane production, is a well-recognized cause of occupational asthma. The major focus of disease prevention efforts to date has been respiratory tract exposure; however, skin exposure may also be an impo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wisnewski, Adam V, Xu, Lan, Robinson, Eve, Liu, Jian, Redlich, Carrie A, Herrick, Christina A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068988/
https://www.ncbi.nlm.nih.gov/pubmed/21414210
http://dx.doi.org/10.1186/1745-6673-6-6
_version_ 1782201297734205440
author Wisnewski, Adam V
Xu, Lan
Robinson, Eve
Liu, Jian
Redlich, Carrie A
Herrick, Christina A
author_facet Wisnewski, Adam V
Xu, Lan
Robinson, Eve
Liu, Jian
Redlich, Carrie A
Herrick, Christina A
author_sort Wisnewski, Adam V
collection PubMed
description BACKGROUND: Methylene diphenyl diisocyanate (MDI), a reactive chemical used for commercial polyurethane production, is a well-recognized cause of occupational asthma. The major focus of disease prevention efforts to date has been respiratory tract exposure; however, skin exposure may also be an important route for inducing immune sensitization, which may promote subsequent airway inflammatory responses. We developed a murine model to investigate pathogenic mechanisms by which MDI skin exposure might promote subsequent immune responses, including respiratory tract inflammation. METHODS: Mice exposed via the skin to varying doses (0.1-10% w/v) of MDI diluted in acetone/olive oil were subsequently evaluated for MDI immune sensitization. Serum levels of MDI-specific IgG and IgE were measured by enzyme-linked immunosorbant assay (ELISA), while respiratory tract inflammation, induced by intranasal delivery of MDI-mouse albumin conjugates, was evaluated based on bronchoalveolar lavage (BAL). Autologous serum IgG from "skin only" exposed mice was used to detect and guide the purification/identification of skin proteins antigenically modified by MDI exposure in vivo. RESULTS: Skin exposure to MDI resulted in specific antibody production and promoted subsequent respiratory tract inflammation in animals challenged intranasally with MDI-mouse albumin conjugates. The degree of (secondary) respiratory tract inflammation and eosinophilia depended upon the (primary) skin exposure dose, and was maximal in mice exposed to 1% MDI, but paradoxically limited in mice receiving 10-fold higher doses (e.g. 10% MDI). The major antigenically-modified protein at the local MDI skin exposure site was identified as albumin, and demonstrated biophysical changes consistent with MDI conjugation. CONCLUSIONS: MDI skin exposure can induce MDI-specific immune sensitivity and promote subsequent respiratory tract inflammatory responses and thus, may play an important role in MDI asthma pathogenesis. MDI conjugation and antigenic modification of albumin at local (skin/respiratory tract) exposure sites may represent the common antigenic link connecting skin exposure to subsequent respiratory tract inflammation.
format Text
id pubmed-3068988
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30689882011-04-01 Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses Wisnewski, Adam V Xu, Lan Robinson, Eve Liu, Jian Redlich, Carrie A Herrick, Christina A J Occup Med Toxicol Research BACKGROUND: Methylene diphenyl diisocyanate (MDI), a reactive chemical used for commercial polyurethane production, is a well-recognized cause of occupational asthma. The major focus of disease prevention efforts to date has been respiratory tract exposure; however, skin exposure may also be an important route for inducing immune sensitization, which may promote subsequent airway inflammatory responses. We developed a murine model to investigate pathogenic mechanisms by which MDI skin exposure might promote subsequent immune responses, including respiratory tract inflammation. METHODS: Mice exposed via the skin to varying doses (0.1-10% w/v) of MDI diluted in acetone/olive oil were subsequently evaluated for MDI immune sensitization. Serum levels of MDI-specific IgG and IgE were measured by enzyme-linked immunosorbant assay (ELISA), while respiratory tract inflammation, induced by intranasal delivery of MDI-mouse albumin conjugates, was evaluated based on bronchoalveolar lavage (BAL). Autologous serum IgG from "skin only" exposed mice was used to detect and guide the purification/identification of skin proteins antigenically modified by MDI exposure in vivo. RESULTS: Skin exposure to MDI resulted in specific antibody production and promoted subsequent respiratory tract inflammation in animals challenged intranasally with MDI-mouse albumin conjugates. The degree of (secondary) respiratory tract inflammation and eosinophilia depended upon the (primary) skin exposure dose, and was maximal in mice exposed to 1% MDI, but paradoxically limited in mice receiving 10-fold higher doses (e.g. 10% MDI). The major antigenically-modified protein at the local MDI skin exposure site was identified as albumin, and demonstrated biophysical changes consistent with MDI conjugation. CONCLUSIONS: MDI skin exposure can induce MDI-specific immune sensitivity and promote subsequent respiratory tract inflammatory responses and thus, may play an important role in MDI asthma pathogenesis. MDI conjugation and antigenic modification of albumin at local (skin/respiratory tract) exposure sites may represent the common antigenic link connecting skin exposure to subsequent respiratory tract inflammation. BioMed Central 2011-03-17 /pmc/articles/PMC3068988/ /pubmed/21414210 http://dx.doi.org/10.1186/1745-6673-6-6 Text en Copyright ©2011 Wisnewski et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wisnewski, Adam V
Xu, Lan
Robinson, Eve
Liu, Jian
Redlich, Carrie A
Herrick, Christina A
Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses
title Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses
title_full Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses
title_fullStr Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses
title_full_unstemmed Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses
title_short Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses
title_sort immune sensitization to methylene diphenyl diisocyanate (mdi) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068988/
https://www.ncbi.nlm.nih.gov/pubmed/21414210
http://dx.doi.org/10.1186/1745-6673-6-6
work_keys_str_mv AT wisnewskiadamv immunesensitizationtomethylenediphenyldiisocyanatemdiresultingfromskinexposurealbuminasacarrierproteinconnectingskinexposuretosubsequentrespiratoryresponses
AT xulan immunesensitizationtomethylenediphenyldiisocyanatemdiresultingfromskinexposurealbuminasacarrierproteinconnectingskinexposuretosubsequentrespiratoryresponses
AT robinsoneve immunesensitizationtomethylenediphenyldiisocyanatemdiresultingfromskinexposurealbuminasacarrierproteinconnectingskinexposuretosubsequentrespiratoryresponses
AT liujian immunesensitizationtomethylenediphenyldiisocyanatemdiresultingfromskinexposurealbuminasacarrierproteinconnectingskinexposuretosubsequentrespiratoryresponses
AT redlichcarriea immunesensitizationtomethylenediphenyldiisocyanatemdiresultingfromskinexposurealbuminasacarrierproteinconnectingskinexposuretosubsequentrespiratoryresponses
AT herrickchristinaa immunesensitizationtomethylenediphenyldiisocyanatemdiresultingfromskinexposurealbuminasacarrierproteinconnectingskinexposuretosubsequentrespiratoryresponses